 |
Benzydamine hydrochloride |
|---|---|
| Trade Name | Tantum |
| Orphan Indication | Prophylactic treatment of oral mucositis resulting from radiation therapy for head and neck cancer |
| USA Market Approval | USA |
| USA Designation Date | 1998-05-18 00:00:00 |
| Sponsor | Angelini Pharmaceuticals, Inc.;70 Grand Avenue;River Edge, New Jersey, 07661 |
